SCHEMBL4296233

SCHEMBL4296233

OCc1cc2ccncc2c2cc(Br)ccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 2/20 0.47
KDM4E B2RXH2 3/20 0.41
HTT P42858 2/20 0.41
POLB P06746 1/20 0.41
RAD52 P43351 1/20 0.41
HASPIN Q8TF76 1/20 0.40
CHUK O15111 1/20 0.39
HIPK2 Q9H2X6 1/20 0.38
NCOA3 Q9Y6Q9 1/20 0.38
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
RXFP1 Q9HBX9 2/20 0.37
PLAU P00749 2/20 0.36
KIT P10721 1/20 0.35
ROS1 P08922 1/20 0.34
RPS6KB1 P23443 1/20 0.34
IMPDH2 P12268 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13659553 0.82 KDM4E (0.59) KDM4EHTTPOLBRAD52HASPIN
SCHEMBL4295258 0.82 KDM4E (0.41) KDM4EHTTPOLBRAD52HASPIN
SCHEMBL4292177 0.81 CSNK2A1 (0.43) CHEK1KDM4EHTTPOLBRAD52
SCHEMBL13659628 0.79 CHEK1 (0.52) CHEK1KDM4EHTTPOLBRAD52
SCHEMBL4291875 0.77 PTGS1 (0.33) CHEK1KDM4EHTTPOLBRAD52
SCHEMBL28455526 0.75 HIPK2 (0.53) KDM4EHTTPOLBRAD52CHUK
SCHEMBL4302560 0.75 RXFP1 (0.64) KDM4EHTTPOLBHIPK2KMT2A
SCHEMBL9475347 0.74 CHEK1 (0.50) CHEK1KMT2AMEN1RXFP1ALDH1A1
SCHEMBL4297677 0.73 CCNT1 (0.40) KDM4EHTTPOLBRAD52HASPIN
SCHEMBL4297665 0.73 NCOA3 (0.68) CHEK1KDM4EHTTPOLBRAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090258852-A1 Inhibitors of Checkpoint Kinases MERCK SHARP & DOHME CORP. 2009-10-15 US disclosed
US-20090258852-A1 Inhibitors of Checkpoint Kinases MERCK SHARP & DOHME CORP. 2009-10-15 US disclosed
US-20090258852-A1 Inhibitors of Checkpoint Kinases MERCK SHARP & DOHME CORP. 2009-10-15 US disclosed
WO-2007008502-A2 INHIBITORS OF CHECKPOINT KINASES MERCK & CO., INC. (US) 2007-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258852-A1 Inhibitors of Checkpoint Kinases CHEK1, CHEK2, CDKN1A CHEK1 1/4885KDM4E 366/4885HTT 3947/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.